Product Images Doxepin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Doxepin Hydrochloride NDC 72789-333 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

72789333 lable - 72789333

72789333 lable - 72789333

This is a description for a medication called Doxepin Hydrochloride. Each capsule contains 10 mg of doxepin. The capsules need to be stored in a tight, light-resistant container, which should be kept tightly closed. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), and the medication should be protected from light. The dosage and use instructions can be found in the accompanying prescribing information. The pharmacist should dispense the accompanying medication guide to each patient. The medication should not be used if the seal is broken or missing from the bottle. It is important to keep this and all medications out of the reach of children. The medication is marketed and packaged by PD-Rx Pharmaceuticals, Inc in Oklahoma City, OK. It is manufactured by Contract Pharmacal Corp. The product has an expiration date of 10/2027 and a lot number of D23D71.*

72789334 Lable - 72789334

72789334 Lable - 72789334

Each capsule of this medication contains 25 mg of doxepin hydrochloride. It should be stored in a tightly closed, light-resistant container at a temperature of 20°C to 25°C (68°F to 77°F). The capsules should be protected from light. The medication is dispensed in a child-resistant container. Please refer to the accompanying prescribing information for dosage and use guidance. This medication is manufactured by Contract Pharmacal Corp. and marketed and packaged by PD-Rx Pharmaceuticals, Inc. in Oklahoma City, OK. It is important to keep all medications out of the reach of children. The product has a Tamper-evident seal, and if the seal is broken or missing, it should not be used. The expiration date is 10/2027, and the lot number is D23D71.*

72789335 Lable - 72789335

72789335 Lable - 72789335

72789336 Label - 72789336

72789336 Label - 72789336

Each capsule contains 75 mg of Doxepin hydrochloride. The capsules are to be dispensed in a tightly closed, light-resistant container with a child-resistant closure. They should be stored at a temperature between 20°C and 25°C (68°F and 77°F) and protected from light. The dosage and use instructions can be found in the accompanying prescribing information. The medication should be kept out of the reach of children. The product is marketed and packaged by PD-Rx Pharmaceuticals, Inc. in Oklahoma City and manufactured by Contract Pharmacal Corp. in Hauppauge, NY. The product has an NDC number of 72789-336-30 and a GTIN of 00372789336305. The expiration date is 10/2027, and the lot number is D23D71.*

72789337 Label - 72789337

72789337 Label - 72789337

This text provides information about a medication in the form of capsules containing Doxepin hydrochloride. Each capsule is equivalent to 100 mg of doxepin. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and protected from light. The dosage and use information can be found in the accompanying prescribing information. The pharmacist should dispense the accompanying medication guide to each patient. The text also includes details about the manufacturer and contact information. The medication is tamper-evident, and if the seal is broken or missing, it should not be used. It is important to keep this medication and all others out of the reach of children.*

Structure - Doxepine Structure

Structure - Doxepine Structure

Doxepin HCI is a medication that belongs to the class of tricyclic antidepressants. It is primarily used to treat depression and anxiety disorders. Doxepin HCI works by affecting the balance of certain chemicals in the brain that are responsible for mood regulation. It can also be prescribed to manage chronic insomnia. This medication should be taken only as directed by a healthcare professional, as it may cause drowsiness and other side effects. Common side effects may include dizziness, dry mouth, constipation, and blurred vision. It is important to consult with a doctor before starting or stopping this medication.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.